STRYKER CORP
Stryker Corporation (SYK) is a global medical‑technology company best known for orthopaedics, surgical equipment, neurotechnology and patient-handling systems. Investors should know it sells high-margin implants, powered surgical tools and capital equipment to hospitals and clinics, giving it exposure to both recurring consumable sales and larger, cyclical procedure volumes. Growth drivers include an ageing population, innovation in implants and minimally invasive procedures, geographic expansion and selective acquisitions. Key considerations are sensitivity to elective-surgery cycles, hospital capital spending and regulatory approvals; reimbursement policies and competition from other device makers can also affect results. Stryker has a track record of reinvesting in R&D, pursuing M&A and returning cash to shareholders, but margins and growth rates can vary over time. This is general, educational information only — not personal investment advice. Values can rise and fall and past performance is not a reliable guide. Suitability depends on your circumstances; consider seeking regulated financial advice before investing.
Why It's Moving
Analysts Pile On Bullish Calls for Stryker as Recent Updates Signal Strong Upside Momentum.
- Truist Securities held at $380 on April 15, highlighting Stryker's resilient execution amid sector headwinds.
- BTIG reiterated buy at $397 on April 14, pointing to accelerating Mako robot adoption with over 3,000 systems installed globally.
- Leerink Partners maintained favorable outlook on April 13, driven by two-thirds of U.S. knee procedures now robotic, boosting efficiency and market share.
Analysts Pile On Bullish Calls for Stryker as Recent Updates Signal Strong Upside Momentum.
- Truist Securities held at $380 on April 15, highlighting Stryker's resilient execution amid sector headwinds.
- BTIG reiterated buy at $397 on April 14, pointing to accelerating Mako robot adoption with over 3,000 systems installed globally.
- Leerink Partners maintained favorable outlook on April 13, driven by two-thirds of U.S. knee procedures now robotic, boosting efficiency and market share.
When is the next earnings date for STRYKER CORP (SYK)?
Stryker's next earnings release is scheduled for Thursday, April 30, 2026, after market close. This report will cover the first quarter of fiscal year 2026, ending March 31, 2026, with a press release at approximately 4:05 p.m. ET and webcast at 4:30 p.m. ET. Investors should monitor for the official results and any accompanying guidance.
Stock Performance Snapshot
Analyst Rating
Analysts recommend buying Stryker's stock with a target price of $431.42, indicating strong growth potential.
Financial Health
Stryker Corporation is performing well, with strong profits and cash flow contributing to its growth.
Dividend
Stryker Corporation's dividend yield of 1.03% is low, making it less attractive for dividend-seeking investors. If you invested $1000 you would be paid $10.30 a year in dividends (based on the last 12 months).
View more stocks by downloading the app for FREE
It only takes 60 seconds.
Discover More Opportunities
Abbott
Abbott Laboratories is a global healthcare company that develops and markets a broad range of health care products, including medical devices, diagnostics, nutritionals, and branded generic pharmaceuticals.
AGILENT TECHNOLOGIES INC
Agilent Technologies, Inc. specializes in life sciences, diagnostics and applied markets, providing application-focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. Its segments include Life Sciences and Diagnostics Markets, Agilent CrossLab and Applied Markets. The Life Sciences and Diagnostics Markets segment provides contract development and manufacturing services for pharmaceutical customers as well as solutions that include reagents, instruments, software and consumables which enable customers in the clinical and life sciences research areas to interrogate samples at the cellular and molecular level. The Agilent CrossLab segment spans the entire lab with its services and consumables portfolio in addition to software and laboratory automation solutions, which are designed to improve customer outcomes and represent a range of offerings designed to serve customer needs across end-markets and applications.
ALIGN TECHNOLOGY INC
Align Technology is a medical device company that designs, manufactures and markets a range of dental and orthodontic products.
Baskets Featuring SYK
Healthcare Titans: Brazil Growth vs Currency Volatility
Brazil's healthcare sector is rapidly modernizing, creating significant demand for global innovation in areas like AI and digital health. This basket offers exposure to the US and EU-listed pharmaceutical, medical device, and technology titans that supply this growing market.
Published: October 14, 2025
Explore BasketHealthcare Innovation: MedTech Giants Portfolio 2025
Growing demand for advanced healthcare in Africa highlights the global companies at the forefront of medical technology innovation. This theme offers exposure to US and EU-listed industry leaders in robotic surgery, diagnostic imaging, and other medical devices.
Published: September 22, 2025
Explore BasketWhy You’ll Want to Watch This Stock
Elective Surgery Exposure
Stryker benefits from demand for joint replacements and minimally invasive procedures, though revenues can move with surgical volumes and economic cycles.
Innovation and M&A
Regular new-product launches and selective acquisitions can extend market share, but integration and regulatory approval carry execution risk.
Global Footprint
Diversified geographic presence helps growth and resilience, though it brings exposure to local reimbursement policies and currency fluctuations.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.